Inhibitex Revenue and Competitors
Estimated Revenue & Valuation
- Inhibitex's estimated annual revenue is currently $5.3M per year.
- Inhibitex's estimated revenue per employee is $155,000
Employee Data
- Inhibitex has 34 Employees.
- Inhibitex grew their employee count by 0% last year.
Inhibitex Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $6.2M | 40 | -7% | N/A | N/A |
What Is Inhibitex?
Inhibitex is a clinical-stage biopharmaceutical company dedicated to the development of innovative products that can treat or prevent serious infections. We are applying our expertise in the development of a portfolio of high-value, differentiated infectious disease therapies, each of which has the potential to significantly improve existing standards of care. Our pipeline addresses major viral and bacterial infections, including herpes zoster (shingles), HCV, and S. aureus infections.
keywords:N/A
N/A
Total Funding
34
Number of Employees
$5.3M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Alpharetta
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.9M | 34 | 42% | N/A |
#2 | $3.9M | 34 | 6% | N/A |
#3 | N/A | 34 | 3% | N/A |
#4 | $3.9M | 34 | 0% | N/A |
#5 | $7.3M | 34 | 6% | N/A |